Table 6.
Evaluation of serum vaspin levels in patients with endometrial cancer in relation to subgroups: G1–3, grading 1–3; FIGO, International Federation of Gynecology and Obstetrics; LVSI metastases, lymphovascular space invasion metastases.
| Statistical Parameters | Vaspin [ng/mL] | p | |
|---|---|---|---|
| FIGO I, II | FIGO III, IV | ||
| Range | 0.4–3.8 | 0.1–2.6 | 0.041 |
| Median | 1.5 | 1.0 | |
| Confidence interval | 1.3–2.2 | 0.5–1.2 | |
| Standard deviation | 0.2 | 0.1 | |
| Vaspin [ng/mL] | p | ||
| G1 | G2 | ||
| Range | 1.0–3.8 | 0.8–3.3 | NS |
| Median | 2.0 | 1.6 | |
| Confidence interval | 1.9–2.8 | 1.3–2.2 | |
| Standard deviation | 0.3 | 0.2 | |
| Vaspin [ng/mL] | p | ||
| G2 | G3 | ||
| Range | 0.8–3.3 | 0.1–2.5 | NS |
| Median | 1.6 | 1.1 | |
| Confidence interval | 1.3–2.2 | 0.6–1.4 | |
| Standard deviation | 0.2 | 0.1 | |
| Vaspin [ng/mL] | p | ||
| G1 | G3 | ||
| Range | 1.0–3.8 | 0.1–2.5 | 0.049 |
| Median | 2.0 | 1.1 | |
| Confidence interval | 1.9–2.8 | 0.6–1.4 | |
| Standard deviation | 2.2 | 0.1 | |
| Vaspin [ng/mL] | p | ||
| Superficial myometrial infiltration | Deep myometrial infiltration | ||
| Range | 0.4–4.1 | 0.3–3.9 | NS |
| Median | 2.2 | 2.0 | |
| Confidence interval | 1.9–2.6 | 1.3–2.6 | |
| Standard deviation | 0.4 | 0.2 | |
| Vaspin [ng/mL] | p | ||
| LVSI metastases—yes | LVSI metastases—no | ||
| Range | 0.3–4.1 | 0.5–4.4 | 0.037 |
| Median | 1.8 | 2.8 | |
| Confidence interval | 1.6–3.0 | 1.9–2.9 | |
| Standard deviation | 0.3 | 0.5 | |
| Vaspin [ng/mL] | p | ||
| Presence of angioinvasion—yes | Presence of angioinvasion—no | ||
| Range | 0.1–3.5 | 0.3–4.4 | NS |
| Median | 1.5 | 2.5 | |
| Confidence interval | 1.6–2.2 | 2.1–2.5 | |
| Standard deviation | 0.2 | 0.4 | |
| Vaspin [ng/mL] | p | ||
| Lymph node metastases—yes | Lymph node metastases—no | ||
| Range | 0.1–3.1 | 0.6–4.4 | 0.026 |
| Median | 1.2 | 2.4 | |
| Confidence interval | 0.8–1.4 | 1.8–2.7 | |
| Standard deviation | 0.1 | 0.4 | |